We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STN:TSXStantec Inc Analysis

Data as of 2026-05-13 - not real-time

CA$114.25

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Stantec’s shares are trading near a key support level with the 20‑day SMA just above the current price, while the 14‑day RSI sits in oversold territory, suggesting a potential short‑term bounce. Technical momentum is mixed – the MACD histogram remains negative and the overall trend is neutral, but volume has been increasing, adding credibility to any upward move. The discounted cash‑flow model places fair value well above today’s price, implying a sizable upside horizon, and the dividend yield, coupled with a modest payout ratio, enhances the attractiveness of the stock. Recent corporate developments, including a high‑profile advisory contract with the European Investment Bank on climate adaptation, underscore the firm’s strategic positioning in sustainable infrastructure.
Fundamentally, Stantec delivers solid revenue growth and healthy operating margins, supported by strong operating and free cash flow generation. The balance sheet shows manageable leverage and ample liquidity, while the forward‑looking earnings estimates point to accelerating EPS growth. Analyst sentiment has turned bullish, reflected in a recent upgrade to a strong‑buy rating, and the sector’s blend of growth and value characteristics aligns well with long‑term investment theses.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support with oversold RSI
  • Increasing volume indicating buying interest
  • Potential catalyst from upcoming earnings release

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF fair value
  • Strong revenue growth and expanding margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic climate‑adaptation contract enhancing ESG profile
  • Consistent cash flow generation supporting dividend stability
  • Blend of growth opportunities and attractive valuation

Key Metrics & Analysis

Financial Health

Revenue Growth10.90%
Profit Margin7.38%
P/E Ratio27.2
ROE15.50%
ROA6.51%
Debt/Equity78.60
P/B Ratio4.0
Op. Cash FlowCA$862.9M
Free Cash FlowCA$820.3M
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI31.3
SupportCA$113.09
ResistanceCA$127.45
MA 20CA$122.90
MA 50CA$122.35
MA 200CA$137.55
MACDBearish
VolumeIncreasing
Fear & Greed Index89.43

Valuation

Fair ValueCA$132.58
Target PriceCA$164.09
Upside/Downside43.62%
GradeUndervalued
TypeBlend
Dividend Yield0.86%

Risk Assessment

Beta1.03
Volatility24.70%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.